应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACXP Acurx Pharmaceuticals, LLC*
休市中 05-17 16:00:00 EDT
2.25
+0.09
+4.17%
盘后
2.21
-0.04
-1.78%
19:59 EDT
最高
2.28
最低
2.15
成交量
3.81万
今开
2.15
昨收
2.16
日振幅
5.94%
总市值
3,560万
流通市值
3,019万
总股本
1,582万
成交额
8.42万
换手率
0.28%
流通股本
1,342万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.53%
自选股智能写手 · 05-07
Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.53%
Acurx Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报2.31美元
自选股智能写手 · 05-02
Acurx Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报2.31美元
Acurx Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.31%报2.18美元
自选股智能写手 · 04-30
Acurx Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.31%报2.18美元
Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.47%报1.90美元
自选股智能写手 · 04-22
Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.47%报1.90美元
Acurx Pharmaceuticals, Inc.盘中异动 快速下挫5.16%
自选股智能写手 · 04-20
Acurx Pharmaceuticals, Inc.盘中异动 快速下挫5.16%
Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.56%
自选股智能写手 · 04-18
Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.56%
Acurx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.40%报1.75美元
自选股智能写手 · 04-17
Acurx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.40%报1.75美元
Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.08%报1.68美元
自选股智能写手 · 04-16
Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.08%报1.68美元
Acurx Pharmaceuticals, Inc.盘中异动 急速下挫5.35%
自选股智能写手 · 04-12
Acurx Pharmaceuticals, Inc.盘中异动 急速下挫5.35%
Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.70%报1.82美元
自选股智能写手 · 04-11
Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.70%报1.82美元
Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.79%
自选股智能写手 · 04-04
Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.79%
Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.67%
自选股智能写手 · 03-25
Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.67%
Acurx Pharmaceuticals, Inc.2023财年实现净利润-14.58百万美元,同比减少20.60%
自选股智能写手 · 03-19
Acurx Pharmaceuticals, Inc.2023财年实现净利润-14.58百万美元,同比减少20.60%
加载更多
公司概况
公司名称:
Acurx Pharmaceuticals, LLC*
所属市场:
NASDAQ
上市日期:
--
主营业务:
Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立,于2018年2月开始运营。他们是临床阶段的生物制药公司,致力于开发新型抗生素,用于治疗被世界卫生组织列为优先病原体的细菌引起的感染(“WHO”),美国疾病控制与预防中心(“CDC”)和美国食品和药物管理局(“FDA”)。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性(“AMR”)危机的病原体。
发行价格:
--
{"stockData":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":2.25,"timestamp":1715976000000,"preClose":2.16,"halted":0,"volume":38109,"hourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.25,"latestTime":"19:59 EDT","volume":808,"amount":1766.81,"timestamp":1715990364958},"delay":0,"floatShares":13418479,"shares":15823102,"eps":-1.17776,"marketStatus":"休市中","marketStatusCode":7,"change":0.09,"latestTime":"05-17 16:00:00 EDT","open":2.15,"high":2.2784,"low":2.15,"amount":84243.96118859999,"amplitude":0.059444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.17776,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1624593600000,"adjPreClose":2.16,"preHourTrading":{"tag":"盘前","latestPrice":2.16,"preClose":2.18,"latestTime":"08:33 EDT","volume":3101,"amount":6689.4722384,"timestamp":1715949234849},"postHourTrading":{"tag":"盘后","latestPrice":2.21,"preClose":2.25,"latestTime":"19:59 EDT","volume":808,"amount":1766.81,"timestamp":1715990364958},"volumeRatio":0.6208489263299337},"requestUrl":"/m/hq/s/ACXP/","defaultTab":"news","newsList":[{"id":"2433287075","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433287075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433287075?lang=zh_cn&edition=full","pubTime":"2024-05-07 03:33","pubTimestamp":1715024004,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日03时33分,Acurx Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.53%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司,正在开发一种新型抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050703332487e85e22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050703332487e85e22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432868658","title":"Acurx Pharmaceuticals, Inc.盘中异动 急速拉升5.00%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432868658","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432868658?lang=zh_cn&edition=full","pubTime":"2024-05-02 00:50","pubTimestamp":1714582245,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日00时50分,Acurx Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.00%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.14%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司,正在开发一种新型抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020050457a57de39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020050457a57de39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431846223","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.31%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431846223","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431846223?lang=zh_cn&edition=full","pubTime":"2024-04-30 03:08","pubTimestamp":1714417686,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日03时08分,Acurx Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.31%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司,正在开发一种新型抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300308077a5758ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300308077a5758ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429192204","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.47%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429192204","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429192204?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:13","pubTimestamp":1713795184,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时13分,Acurx Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.47%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222130487e82846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222130487e82846&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428667146","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428667146","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428667146?lang=zh_cn&edition=full","pubTime":"2024-04-20 01:56","pubTimestamp":1713549370,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日01时56分,Acurx Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.16%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200156107a542833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404200156107a542833&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428152591","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428152591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428152591?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:32","pubTimestamp":1713447127,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时32分,Acurx Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.56%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132078790999c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182132078790999c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428346065","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.40%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428346065","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428346065?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:41","pubTimestamp":1713361261,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时41分,Acurx Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.40%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172141018b30114a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172141018b30114a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427889467","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.08%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427889467","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427889467?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:03","pubTimestamp":1713200626,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时03分,Acurx Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.08%。截至发稿,该股报1.68美元/股,成交量1.2638万股,换手率0.08%,振幅7.34%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160103467920a626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160103467920a626&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427732407","title":"Acurx Pharmaceuticals, Inc.盘中异动 急速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427732407","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427732407?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:57","pubTimestamp":1712937473,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日23时57分,Acurx Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.35%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.89%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122357537a5279f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404122357537a5279f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426633447","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大跌5.70%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426633447","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426633447?lang=zh_cn&edition=full","pubTime":"2024-04-11 03:46","pubTimestamp":1712778372,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日03时46分,Acurx Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.70%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.85%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110346127a51ee98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110346127a51ee98&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424482279","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424482279","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424482279?lang=zh_cn&edition=full","pubTime":"2024-04-04 01:12","pubTimestamp":1712164341,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日01时12分,Acurx Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.79%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404011221861e35bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404011221861e35bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422547768","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422547768","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422547768?lang=zh_cn&edition=full","pubTime":"2024-03-25 23:44","pubTimestamp":1711381490,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日23时44分,Acurx Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.67%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Acurx Pharmaceuticals, Inc.公司简介:Acurx Pharmaceuticals Inc 是一家临床阶段的生物制药公司,正在开发一类新的抗生素,用于治疗由世界卫生组织、疾病控制和预防中心以及食品和药物管理局列为优先病原体的细菌引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523445087e7b86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032523445087e7b86a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420967286","title":"Acurx Pharmaceuticals, Inc.2023财年实现净利润-14.58百万美元,同比减少20.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420967286","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420967286?lang=zh_cn&edition=full","pubTime":"2024-03-19 02:14","pubTimestamp":1710785669,"startTime":"0","endTime":"0","summary":"12月31日,Acurx Pharmaceuticals, Inc.公布财报,公告显示公司2023财年净利润为-14.58百万美元,同比减少20.60%;其中营业收入为0.00美元,每股基本收益为-1.15美元。从资产负债表来看,Acurx Pharmaceuticals, Inc.总负债3.04百万美元,其中短期债务0.00美元,资产负债比为2.54,流动比率为2.54。机构评级:截至2023年12月31日,当前有2家机构对Acurx Pharmaceuticals, Inc.目标价做出预测,其中目标均价为12.00美元,其中最低目标价为10.00美元,最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190214318794362f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190214318794362f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acurxpharma.com","stockEarnings":[{"period":"1week","weight":0.1084},{"period":"1month","weight":0.25},{"period":"3month","weight":-0.3023},{"period":"6month","weight":-0.3919},{"period":"1year","weight":-0.2525},{"period":"ytd","weight":-0.4125}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立,于2018年2月开始运营。他们是临床阶段的生物制药公司,致力于开发新型抗生素,用于治疗被世界卫生组织列为优先病原体的细菌引起的感染(“WHO”),美国疾病控制与预防中心(“CDC”)和美国食品和药物管理局(“FDA”)。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性(“AMR”)危机的病原体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093013},{"month":2,"riseRate":0,"avgChangeRate":-0.109365},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.066567},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.033561},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.073101},{"month":6,"riseRate":0.5,"avgChangeRate":0.131881},{"month":7,"riseRate":0,"avgChangeRate":-0.13303},{"month":8,"riseRate":0,"avgChangeRate":-0.054739},{"month":9,"riseRate":0,"avgChangeRate":-0.122993},{"month":10,"riseRate":0.666667,"avgChangeRate":0.855366},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.115447},{"month":12,"riseRate":0.666667,"avgChangeRate":0.07867}],"exchange":"NASDAQ","name":"Acurx Pharmaceuticals, LLC*","nameEN":"Acurx Pharmaceuticals, LLC*"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acurx Pharmaceuticals, LLC*,ACXP,Acurx Pharmaceuticals, LLC*股票,Acurx Pharmaceuticals, LLC*股票老虎,Acurx Pharmaceuticals, LLC*股票老虎国际,Acurx Pharmaceuticals, LLC*行情,Acurx Pharmaceuticals, LLC*股票行情,Acurx Pharmaceuticals, LLC*股价,Acurx Pharmaceuticals, LLC*股市,Acurx Pharmaceuticals, LLC*股票价格,Acurx Pharmaceuticals, LLC*股票交易,Acurx Pharmaceuticals, LLC*股票购买,Acurx Pharmaceuticals, LLC*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}